Compounds > cysteine

cysteine and Thyroid Neoplasms

cysteine has been researched along with Thyroid Neoplasms in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's17 (42.50)18.2507
2000's14 (35.00)29.6817
2010's6 (15.00)24.3611
2020's3 (7.50)2.80

Authors

AuthorsStudies
Iizuka, Y; Inoue, M; Mizowaki, T; Nakamura, K; Sato, GE1
Biarnés, J; de la Bellacasa, JP; Oriola, J; Paniello, B; Sanchez, A1
Andreou, E; Cariolou, MA; Christophidou-Anastasiadou, V; Christopoulos, G; Fanis, P; Frangos, S; Kleanthous, M; Manoli, P; Mavrommatis, M; Neocleous, V; Nicolaou, S; Phylactou, LA; Skordis, N; Spanou-Aristidou, E; Tanteles, GA1
Camacho, CP; Cerutti, JM; Delcelo, R; Dias-da-Silva, MR; França, MI; Hoff, AO; Kasamatsu, TS; Lindsey, SC; Machado, AL; Maciel, RM; Salim, CP; Signorini, PS; Valente, FO1
Höög, A; Juhlin, CC; Larsson, C; Liu, T; Sofiadis, A; Wang, N; Xu, D; Zedenius, J1
Boutati, E; Economopoulos, T; Hadjidakis, D; Kamakari, S; Panayiotides, IG; Peppa, M; Peros, G; Pikounis, V; Raptis, SA1
Mukherjee, S; Zakalik, D1
Huang, Y; Liu, YM; Shi, M; Ye, F; Zhao, S1
Barollo, S; Mian, C; Opocher, G; Sartorato, P; Zane, M1
Balsalobre, MD; Carbonell, P; Glower, G; Parrilla, P; Pomares, F; Ríos, A; Rodríguez, GJ; Sola, J; Tébar, J; Torregrosa, NM1
Barrera-León, O; Beattie, KL; Colin-Tovar, C; Espinosa-Lara, M; González-Yebra, B; Maldonado-Rodríguez, R; Méndez-Tenorio, A; Salcedo-Vargas, M; Santiago-Hernández, JC1
Carnaille, B; Chabrier, G; Conte-Devolx, B; Gibelin, H; Henry, JF; Jaeck, D; Kraimps, JL; Murat, A; Niccoli-Sire, P; Proye, C; Rohmer, V; Ronceray, J; Visset, J1
Dralle, H; Holzhausen, HJ; Machens, A; Raue, F; Schneyer, U1
Altaner, C; Altanerova, V; Breza, J; Kostalova, L; Poturnajova, M1
Fitze, G1
Beason-Held, LL; Brown, BP; Fletcher, DW; Schraml, FV1
Abrescia, C; Ibáñez, CF; Kjaer, S; Kurokawa, K; Perrinjaquet, M1
Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E1
Becherini, L; Cantini, G; Ercolino, T; Gaglianò, MS; Lombardi, A; Luconi, M; Mannelli, M; Piscitelli, E; Serio, M1
Arnone, MI; Di Lauro, R; Zannini, M1
Carlomagno, F; Colantuoni, V; de Franciscis, V; Fusco, A; Panariello, L; Quadro, L; Salvatore, D; Santoro, M1
Bowden, DW; Mao, J; Maurer, LH; Memoli, VA; Noll, WW; Nutile-McMenemy, N; Schuster, MK; Xue, F; Yu, H1
Elsdon, MJ; Eng, C; Gardner, E; Healey, CS; Kwok, JB; Love, DR; Mole, SE; Moore, JK; Mulligan, LM; Papi, L1
Kimura, T; Saito, S; Yokogoshi, Y; Yoshimoto, K1
Gagel, RF1
Komminoth, P1
Ceccherini, I; Elisei, R; Mancusi, F; Martino, E; Molinaro, E; Pacini, F; Pinchera, A; Romei, C; Romeo, G1
Bagni, B; Cattaruzzi, E; Englaro, E; Guerra, UP; Orsolon, P1
Clayton, D; Cote, G; Eng, C; Fink, M; Frank-Raue, K; Gagel, RF; Hendy, GN; Komminoth, P; Lenoir, G; Lips, CJ; Marsh, DJ; Mulligan, LM; Niederle, B; Nishisho, I; Noll, WW; Nordenskjöld, M; Pacini, F; Raue, F; Robinson, BG; Romei, C; Schuffenecker, I; Takai, SI; van Amstel, HK; Xue, F; Zedenius, J1
Blijham, GH; de Valk, IA; Höppener, JW; Jansen-Schillhorn van Veen, JM; Landsvater, RM; Lips, CJ; Moers, AM; Schaap, C; van Amstel, HK; Vroom, TM1
Bugalho, MJ; Frade, JP; Limbert, E; Santos, JR; Sobrinho, L1
Bongarzone, I; Ceccherini, I; Gullo, M; Matera, I; Mondellini, P; Pacini, F; Pasini, B; Pierotti, MA; Pinchera, A; Romei, C; Romeo, G; Santamaria, G; Scopsi, L1
Asai, N; Ito, S; Iwashita, T; Iwata, Y; Murakami, H; Sobue, G; Takahashi, M1
García-Mayor, RV; Halperin, I; Oriola, J; Páramo, C; Rivera-Fillat, F1
Bauters, C; Buisine, MP; Calender, A; Caron, P; Crepin, M; Giraud, S; Houcke, ML; Kerckaert, JP; Pigny, P; Porchet, N; Wemeau, JL1
Boehm, BO; Dralle, H; Gimm, O; Hinze, R; Höppner, W; Machens, A1
Baldet, L; Bezieau, S; Chabrier, G; Conte-Devolx, B; Franc, S; Giraud, S; Kottler, ML; Maes, B; Morange, S; Murat, A; Niccoli-Sire, P; Rohmer, V; Savagner, F1
Blanes, A; de Miguel, M; Diaz-Cano, SJ; Tashjian, R; Wolfe, HJ1
Hayashi, Y; Kurokawa, Y; Maekawa, A; Takahashi, M1

Reviews

7 review(s) available for cysteine and Thyroid Neoplasms

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide

2023
Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
    European journal of endocrinology, 2008, Volume: 159, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Carcinoma, Medullary; Cysteine; Female; Glycine; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Pedigree; Phenotype; Point Mutation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Syndrome; Thyroid Neoplasms; Young Adult

2008
RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in clinical management.
    Clinical genetics, 2011, Volume: 79, Issue:1

    Topics: Adolescent; Adult; Child; Child, Preschool; Codon; Cysteine; Female; Genetic Association Studies; Germ-Line Mutation; Humans; Infant; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Penetrance; Point Mutation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Thyroid Neoplasms; Young Adult

2011
RET codon 609 mutations: a contribution for better clinical managing.
    Clinics (Sao Paulo, Brazil), 2012, Volume: 67 Suppl 1

    Topics: Carcinoma, Medullary; Carcinoma, Neuroendocrine; Codon; Cysteine; Genetic Association Studies; Germ-Line Mutation; Humans; Hyperparathyroidism; Italy; Multiple Endocrine Neoplasia Type 2a; Pedigree; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Serine; Thyroid Neoplasms

2012
Management of patients with hereditary medullary thyroid carcinoma.
    European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2004, Volume: 14, Issue:6

    Topics: Carcinoma, Medullary; Chromosome Mapping; Cysteine; Genetic Counseling; Hirschsprung Disease; Humans; Multiple Endocrine Neoplasia Type 2a; Mutation, Missense; Oncogene Proteins; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Risk Assessment; Signal Transduction; Thyroid Neoplasms; Thyroidectomy

2004
Putting the bits and pieces of the RET proto-oncogene puzzle together.
    Bone, 1995, Volume: 17, Issue:2 Suppl

    Topics: Amino Acid Sequence; Base Sequence; Carcinoma; Cysteine; Drosophila Proteins; Gene Expression; Hirschsprung Disease; Humans; Male; Molecular Sequence Data; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Phosphorylation; Point Mutation; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1995
Toxicity and carcinogenicity of potassium bromate--a new renal carcinogen.
    Environmental health perspectives, 1990, Volume: 87

    Topics: Adenocarcinoma; Administration, Oral; Animals; Bread; Bromates; Bromides; Carcinogenicity Tests; Carcinogens; Carcinoma, Renal Cell; Chromosome Aberrations; Cocarcinogenesis; Cricetinae; Cysteine; Dose-Response Relationship, Drug; Fish Products; Food Additives; Food Handling; Glutathione; Hair Preparations; Hearing Loss; Humans; Japan; Kidney Diseases; Kidney Neoplasms; Maximum Allowable Concentration; Mesocricetus; Mesothelioma; Mice; Mutagenicity Tests; Occupational Diseases; Peritoneal Neoplasms; Potassium; Potassium Compounds; Rats; Rats, Inbred F344; Species Specificity; Thyroid Neoplasms; United Kingdom; United States

1990

Trials

1 trial(s) available for cysteine and Thyroid Neoplasms

ArticleYear
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
    Science & sports, 2023, Apr-04

    Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosphate; Adsorption; Adult; Africa, Eastern; Aged; Air Pollutants; Air Pollution; Air Pollution, Indoor; Alcohol Drinking; Allergens; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Antibodies; Antibodies, Immobilized; Antigen Presentation; Antigens, CD; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Aptamers, Nucleotide; Asthma; Asthma, Exercise-Induced; Atrophy; Autophagy; Azoospermia; Bacillus cereus; Bacterial Infections; Beclin-1; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biofouling; Biological Monitoring; Biomarkers; Biomarkers, Tumor; Biosensing Techniques; Blastocyst; Bone Neoplasms; Bone Regeneration; Bronchoconstriction; Burkitt Lymphoma; C9orf72 Protein; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Cardiomyopathies; Caregivers; Carmine; Case-Control Studies; Catalysis; Cattle; Cause of Death; CCAAT-Enhancer-Binding Protein-alpha; CD8-Positive T-Lymphocytes; Cefepime; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Transdifferentiation; Chelating Agents; Chemical and Drug Induced Liver Injury, Chronic; Chemoradiotherapy, Adjuvant; Child; Child, Preschool; China; Chlorquinaldol; Cholangiocarcinoma; Cholera; Chromatin; Clinical Trials as Topic; Cognitive Dysfunction; Cohort Studies; Colonic Neoplasms; Colorectal Neoplasms; Colorimetry; Cooking; Coordination Complexes; COVID-19; Creatinine; CRISPR-Cas Systems; Critical Care; Critical Illness; Cross-Sectional Studies; Cryopreservation; Cryoprotective Agents; Cysteine; Cytokines; Device Removal; Diet; Diet, High-Fat; Diet, Mediterranean; Dietary Supplements; Dimethyl Sulfoxide; Dipeptides; Disease Models, Animal; Dithiothreitol; DNA; DNA Repeat Expansion; DNA, Bacterial; DNA, Complementary; Dopamine; Electrochemical Techniques; Electrodes; Endocannabinoids; Environmental Exposure; Environmental Monitoring; Environmental Pollutants; Enzyme-Linked Immunosorbent Assay; Erlotinib Hydrochloride; Escherichia coli; Escherichia coli O157; Esophageal Neoplasms; Esophagitis, Peptic; Ethylene Glycol; Europium; Exanthema; Fallopian Tubes; Feces; Female; Fertilization in Vitro; Fluoresceins; Fluorescent Dyes; Follicle Stimulating Hormone; Follow-Up Studies; Food Microbiology; Forced Expiratory Volume; Forkhead Transcription Factors; Frontotemporal Dementia; G-Quadruplexes; Galactose; Gastroenteritis; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gastrointestinal Neoplasms; Gastrointestinal Tract; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genital Neoplasms, Female; Genome-Wide Association Study; Genome, Viral; Genomics; Genotype; Glucose; Glutathione; Glycerol; Gold; Graphite; GTPase-Activating Proteins; Heat-Shock Proteins; Heme Oxygenase-1; Hepacivirus; Hepatitis C; Hepatocytes; Histamine; Histocompatibility Antigens Class II; Hoarseness; Hospice and Palliative Care Nursing; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydroxybenzoates; Hydroxyl Radical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Hysteroscopy; Immunoassay; Indigo Carmine; Inflammation; Inflammatory Bowel Diseases; Insulin Resistance; Intensive Care Units; Interleukin-11; Interleukin-6; Interleukins; Iodine Radioisotopes; Iran; Iridium; Islets of Langerhans; Kinetics; Lactation; Lactobacillus; Lactobacillus plantarum; Lamins; Latin America; Lead; Lectins; Leukopenia; Ligands; Limit of Detection; Lipopolysaccharides; Lipoprotein Lipase; Liver; Liver Cirrhosis; Liver Neoplasms; Lolium; Luminescent Measurements; Luminol; Lung; Luteinizing Hormone; Macrophages; Magnetic Phenomena; Magnetic Resonance Imaging; Male; Malnutrition; Maltose; Manganese Compounds; Maternal Nutritional Physiological Phenomena; Melatonin; Metabolic Engineering; Metal Nanoparticles; Metallocenes; Metaplasia; Methicillin-Resistant Staphylococcus aureus; Methylation; Mevalonic Acid; Mexico; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; Microbiota; MicroRNAs; Milk; Mitomycin; Molecular Diagnostic Techniques; Molecular Docking Simulation; Monte Carlo Method; Moringa oleifera; Multiple Sclerosis; Muscle Strength; Muscle, Skeletal; Nanocomposites; Nanotubes, Carbon; Neoadjuvant Therapy; Neoplasms; Neurodegenerative Diseases; Neurotransmitter Agents; NF-E2-Related Factor 2; Nickel; Nitrogen Dioxide; Non-alcoholic Fatty Liver Disease; Nucleic Acid Amplification Techniques; Nucleic Acid Hybridization; Nucleocapsid Proteins; Nutritional Status; Obesity; Osteogenesis; Osteosarcoma; Oxidation-Reduction; Oxides; Oxygen; Oxyquinoline; Pain; Palliative Care; Pancreatic Neoplasms; Pandemics; Particulate Matter; Peroxidase; Peroxidases; Phagocytosis; Phaseolus; Photothermal Therapy; Point-of-Care Systems; Polyethyleneimine; Polymers; Polymorphism, Single Nucleotide; Polysomnography; Postoperative Complications; Pregnancy; Pregnant Women; Prenatal Exposure Delayed Effects; Prevalence; Printing, Three-Dimensional; Probability; Probiotics; Prognosis; Prophages; Prospective Studies; Proteomics; Proto-Oncogene Proteins; Pseudomonas aeruginosa; Pseudomonas putida; Pulmonary Disease, Chronic Obstructive; Pulmonary Embolism; Pyridines; Pyrroles; Quality of Life; Quinolones; Rabbits; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptors, Histamine; Receptors, Histamine H2; Recombinases; Rectal Neoplasms; Reperfusion Injury; Respiration; Respiratory Function Tests; Respiratory Rate; Respiratory Sounds; Retrospective Studies; rho GTP-Binding Proteins; Risk Assessment; Risk Factors; RNA; RNA, Messenger; RNA, Ribosomal, 16S; Robotic Surgical Procedures; Running; Rural Population; Saccharomyces cerevisiae; Salpingectomy; Sarcopenia; SARS-CoV-2; Seeds; Semen; Sensitivity and Specificity; Sepsis; Shock, Septic; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Skin Neoplasms; Sleep Apnea, Obstructive; Soil; Spain; Spectrum Analysis, Raman; Sperm Retrieval; Spermatozoa; Spirometry; Staphylococcus aureus; STAT3 Transcription Factor; Stereoisomerism; Sterilization, Tubal; Stroke Volume; Sulfadiazine; Sulfites; Superoxide Dismutase; Surface Plasmon Resonance; tau Proteins; Testis; Testosterone; Thioredoxin-Disulfide Reductase; Thyroid Neoplasms; Thyroidectomy; Trans-Activators; Transcription Factor AP-1; Treatment Outcome; Triazoles; Triclosan; Trifluridine; Tumor Microenvironment; Tumor Necrosis Factor-alpha; United States; Uracil; Vagina; Vegetables; Ventricular Function, Left; Ventricular Pressure; Vibrio cholerae; Vietnam; Virulence; Vital Capacity; Vitrification; Walking; Water; Water Pollutants, Radioactive; Whole Genome Sequencing; Wind; YAP-Signaling Proteins; Zeolites; Zinc Oxide

2023

Other Studies

33 other study(ies) available for cysteine and Thyroid Neoplasms

ArticleYear
Role of albumin Cys34 redox state in the progression of differentiated thyroid carcinoma and induction of ferroptosis.
    Free radical biology & medicine, 2023, 11-20, Volume: 209, Issue:Pt 1

    Topics: Adenocarcinoma; Cysteine; Ferroptosis; Humans; Iodine Radioisotopes; Oxidation-Reduction; Retrospective Studies; Serum Albumin, Human; Thyroid Neoplasms

2023
A novel germline variant in RET gene resulting in an additional cysteine in a family with familial medullary thyroid carcinoma.
    Familial cancer, 2021, Volume: 20, Issue:3

    Topics: Adult; Aged; Carcinoma, Medullary; Cysteine; Female; Germ-Line Mutation; Heterozygote; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Pedigree; Phenotype; Prophylactic Surgical Procedures; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Thyroidectomy

2021
Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect.
    Journal of endocrinological investigation, 2018, Volume: 41, Issue:10

    Topics: Adult; Arginine; Carcinoma, Medullary; Cohort Studies; Cyprus; Cysteine; Female; Founder Effect; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Pedigree; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms

2018
A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives.
    Clinical endocrinology, 2014, Volume: 80, Issue:2

    Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Child; Child, Preschool; Cysteine; Family Health; Female; Follow-Up Studies; Glycine; Humans; Male; Metanephrine; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation; Pedigree; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Thyroidectomy; Time Factors; Young Adult

2014
TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
    Cancer, 2014, Oct-01, Volume: 120, Issue:19

    Topics: Adenoma; Adult; Aged; Cysteine; Enzyme Activation; Female; GTP Phosphohydrolases; Humans; Male; Membrane Proteins; Middle Aged; Mutation; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Telomerase; Threonine; Thyroid Neoplasms

2014
Determination of intracellular sulphydryl compounds by microchip electrophoresis with selective chemiluminescence detection.
    Journal of chromatography. A, 2010, Sep-03, Volume: 1217, Issue:36

    Topics: Cysteine; Electrophoresis, Microchip; Erythrocytes; Glutathione; Hemoglobins; Humans; Linear Models; Liver Neoplasms; Luminescent Measurements; Reproducibility of Results; Sensitivity and Specificity; Sulfhydryl Compounds; Thyroid Neoplasms

2010
Prophylactic thyroidectomy in MEN 2A syndrome: experience in a single center.
    Journal of the American College of Surgeons, 2002, Volume: 195, Issue:2

    Topics: Adolescent; Adult; Calcitonin; Child; Child, Preschool; Cysteine; Drosophila Proteins; Female; Humans; Infant; Male; Multiple Endocrine Neoplasia Type 2a; Mutation; Neoplasm Recurrence, Local; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Function Tests; Thyroid Neoplasms; Thyroidectomy; Tyrosine

2002
Detection of mutations in RET proto-oncogene codon 634 through double tandem hybridization.
    Molecular biotechnology, 2003, Volume: 25, Issue:2

    Topics: Amino Acid Sequence; Base Sequence; Carcinoma, Medullary; Cysteine; DNA Mutational Analysis; Heterozygote; Humans; Molecular Sequence Data; Mutation; Nucleic Acid Hybridization; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

2003
When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
    Surgery, 2003, Volume: 134, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Calcitonin; Carcinoma, Medullary; Child; Cysteine; Gastrointestinal Hormones; Heterozygote; Humans; Middle Aged; Mutation; Oncogene Proteins; Pentagastrin; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome

2003
Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutation.
    Surgery, 2004, Volume: 136, Issue:5

    Topics: Arginine; Brain Stem Neoplasms; Cysteine; Female; Germ-Line Mutation; Humans; Male; Pedigree; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

2004
Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome.
    Journal of molecular medicine (Berlin, Germany), 2005, Volume: 83, Issue:4

    Topics: Adrenal Gland Neoplasms; Carcinoma, Medullary; Cysteine; Exons; Female; Gene Frequency; Genetic Linkage; Germ-Line Mutation; Humans; Male; Multiple Endocrine Neoplasia Type 2a; Oncogene Proteins; Pedigree; Pheochromocytoma; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Serine; Thyroid Neoplasms

2005
Cerebral accumulation of Tc-99m ethyl cysteinate dimer (ECD) in severe, transient hypothyroidism.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2006, Volume: 26, Issue:3

    Topics: Adult; Anxiety; Cerebral Cortex; Cysteine; Depression; Female; Follow-Up Studies; Humans; Hypothyroidism; Male; Neuropsychological Tests; Organotechnetium Compounds; Psychomotor Disorders; Sensitivity and Specificity; Severity of Illness Index; Thyroid Neoplasms; Thyroidectomy; Tomography, Emission-Computed, Single-Photon

2006
Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations.
    Oncogene, 2006, Nov-09, Volume: 25, Issue:53

    Topics: Alanine; Amino Acid Sequence; Animals; Cell Membrane; Cysteine; Dimerization; Disulfides; Drosophila melanogaster; Drosophila Proteins; Gene Expression; Glial Cell Line-Derived Neurotrophic Factor; Humans; Molecular Sequence Data; Multiple Endocrine Neoplasia Type 2a; Mutation; Protein Binding; Proto-Oncogene Proteins c-ret; Sequence Alignment; Sequence Homology, Amino Acid; Thyroid Neoplasms

2006
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:8

    Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution

2007
The Y606C RET mutation causes a receptor gain of function.
    Clinical endocrinology, 2008, Volume: 69, Issue:2

    Topics: Amino Acid Substitution; Animals; Base Sequence; Carcinoma, Medullary; Cysteine; Female; Germ-Line Mutation; Humans; Mice; Middle Aged; Multiple Endocrine Neoplasia Type 2a; NIH 3T3 Cells; Proto-Oncogene Proteins c-ret; Thyroid Neoplasms; Tyrosine

2008
The DNA binding activity and the dimerization ability of the thyroid transcription factor I are redox regulated.
    The Journal of biological chemistry, 1995, May-19, Volume: 270, Issue:20

    Topics: Alkylation; Animals; Base Sequence; Binding Sites; Consensus Sequence; Cysteine; Cystine; Diamide; Dithiothreitol; DNA; DNA-Binding Proteins; Glutathione; HeLa Cells; Homeodomain Proteins; Humans; Molecular Sequence Data; Oxidation-Reduction; Promoter Regions, Genetic; Protein Conformation; Rats; Recombinant Fusion Proteins; Sequence Alignment; Sequence Homology, Nucleic Acid; Thyroid Neoplasms; Tumor Cells, Cultured

1995
Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line.
    Biochemical and biophysical research communications, 1995, Feb-27, Volume: 207, Issue:3

    Topics: Base Sequence; Carcinoma, Medullary; Codon; Cysteine; Drosophila Proteins; Exons; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Tryptophan; Tumor Cells, Cultured

1995
Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.
    Human molecular genetics, 1994, Volume: 3, Issue:4

    Topics: Base Sequence; Carcinoma, Medullary; Cysteine; DNA Mutational Analysis; Drosophila Proteins; Genetic Carrier Screening; Humans; Molecular Sequence Data; Multiple Endocrine Neoplasia; Point Mutation; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1994
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
    Nature, 1993, Jun-03, Volume: 363, Issue:6428

    Topics: Amino Acid Sequence; Base Sequence; Carcinoma; Codon; Cysteine; DNA Mutational Analysis; DNA, Neoplasm; DNA, Single-Stranded; Drosophila Proteins; Germ Cells; Heterozygote; Humans; Molecular Sequence Data; Multiple Endocrine Neoplasia; Mutation; Pheochromocytoma; Polymerase Chain Reaction; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1993
Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma.
    Endocrine journal, 1995, Volume: 42, Issue:4

    Topics: Adrenal Gland Neoplasms; Aged; Alleles; Base Sequence; Carcinoma, Medullary; Cysteine; DNA, Neoplasm; Exons; Female; Germ-Line Mutation; Humans; Leukocytes; Male; Middle Aged; Molecular Sequence Data; Pheochromocytoma; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogenes; Thyroid Neoplasms; Tumor Cells, Cultured

1995
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1995, Volume: 79

    Topics: Adrenal Gland Neoplasms; Awards and Prizes; Codon; Cysteine; Diagnosis, Differential; Drosophila Proteins; Genetic Carrier Screening; Humans; Hyperplasia; Methionine; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Pathology; Pheochromocytoma; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Threonine; Thyroid Neoplasms

1995
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:4

    Topics: Adult; Aged; Amino Acid Sequence; Base Sequence; Calcitonin; Carcinoma, Medullary; Cysteine; DNA; DNA Primers; DNA, Neoplasm; Drosophila Proteins; Exons; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Point Mutation; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Recurrence; Restriction Mapping; Thyroid Neoplasms; Tyrosine

1996
A brain metastasis, with no uptake of 99mTc-ECD, secondary to Hurtle cell carcinoma of the thyroid.
    Minerva endocrinologica, 1995, Volume: 20, Issue:4

    Topics: Adenocarcinoma; Aged; Brain Neoplasms; Cysteine; Female; Humans; Organotechnetium Compounds; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon

1995
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
    JAMA, 1996, Nov-20, Volume: 276, Issue:19

    Topics: Carcinoma, Medullary; Codon; Cysteine; Drosophila Proteins; Hirschsprung Disease; Humans; Hyperparathyroidism; Multiple Endocrine Neoplasia Type 2a; Mutation; Phenotype; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1996
Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    The American journal of medicine, 1996, Volume: 101, Issue:6

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Medullary; Cysteine; DNA Probes; Drosophila Proteins; Female; Genotype; Germ-Line Mutation; Humans; Hyperparathyroidism; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Pedigree; Phenotype; Pheochromocytoma; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1996
Molecular analysis of the RET proto-oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine-rich domain.
    European journal of endocrinology, 1997, Volume: 136, Issue:4

    Topics: Adult; Aged; Base Sequence; Calcitonin; Carcinoma, Medullary; Cysteine; DNA, Neoplasm; Drosophila Proteins; Electrophoresis, Polyacrylamide Gel; Exons; Extracellular Matrix; Female; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia; Point Mutation; Polymerase Chain Reaction; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1997
Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene.
    Oncogene, 1997, May-29, Volume: 14, Issue:21

    Topics: 3T3 Cells; Adult; Animals; Carcinoma, Medullary; Cell Transformation, Neoplastic; Cysteine; Drosophila Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Sequence Deletion; Thyroid Neoplasms; Transfection

1997
Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
    Cancer research, 1997, Jul-15, Volume: 57, Issue:14

    Topics: 3T3 Cells; Animals; Carcinoma, Medullary; Cysteine; Drosophila Proteins; Hirschsprung Disease; Humans; Mice; Molecular Weight; Multiple Endocrine Neoplasia Type 2a; Mutation; Phenotype; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1997
Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma.
    American journal of medical genetics, 1998, Jul-07, Volume: 78, Issue:3

    Topics: Carcinoma, Medullary; Cysteine; DNA Primers; Drosophila Proteins; Exons; Female; Genes, Dominant; Genetic Testing; Genotype; Humans; Male; Multiple Endocrine Neoplasia; Pedigree; Phenotype; Point Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

1998
A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:5

    Topics: Adult; Carcinoma, Medullary; Child; Coatomer Protein; Cysteine; Exons; Female; Germ-Line Mutation; Hirschsprung Disease; Humans; Male; Membrane Proteins; Middle Aged; Mutation; Pedigree; Reverse Transcriptase Polymerase Chain Reaction; Thyroid Neoplasms

1999
Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:3

    Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Child; Child, Preschool; Codon; Cysteine; Drosophila Proteins; Exons; Female; Genotype; Humans; Male; Middle Aged; Mutation; Phenotype; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms

2001
Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:8

    Topics: Adult; Calcitonin; Carcinoma, Medullary; Cysteine; Databases as Topic; Drosophila Proteins; Exons; Female; France; Genetic Carrier Screening; Genetic Linkage; Genotype; Humans; Hyperplasia; Lymphatic Metastasis; Male; Middle Aged; Pentagastrin; Phenotype; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy

2001
Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:8

    Topics: Amino Acid Substitution; Antigens, Nuclear; Autoantigens; Calcitonin; Carcinoma, Medullary; Cysteine; DNA Primers; Drosophila Proteins; Female; Focal Epithelial Hyperplasia; Genes, Retinoblastoma; Germ-Line Mutation; Humans; Ki-67 Antigen; Loss of Heterozygosity; Multiple Endocrine Neoplasia Type 2a; Nerve Tissue Proteins; Neurofibromin 1; Nuclear Proteins; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Diseases; Thyroid Neoplasms; Thyroidectomy; Tyrosine

2001